Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Diagnostic Value of Dermal Optical Coherence Tomography (D-OCT) for Clinically Suspected Basal Cell Carcinoma Lesion (BCC) in the Periocular Area

NCT06279143 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.

NCT NCT06279143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06279143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Diagnostic Value of Dermal Optical Coherence Tomography (D-OCT) for Clinically Suspected Basal Cell Carcinoma Lesion (BCC) in the Periocular Area
Lead sponsor
Vejle Hospital
Phase
Observational
Overall status
Completed
Start date
April 4, 2024
Completion date
May 22, 2026
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bcc, bcc - basal cell carcinoma, eyelid diseases, eyelid tumor, skin diseases